Back to Epoch Investment Partners, Inc. Epoch Investment Partners, Inc.

REGNREGN
10 quarters

Position history for Epoch Investment Partners, Inc.Epoch Investment Partners, Inc.'s holdings in REGENERON PHARMACEUTICALS

Epoch Investment Partners, Inc. holds 186,850 shares of REGN (REGENERON PHARMACEUTICALS), worth $116.5M as of 2026-Q2. The position was decreased (-21.7% shares). REGN represents 0.7% of Epoch Investment Partners, Inc.'s portfolio.

Current Value

$116.5M

Current Shares

186,850

Total Value Change

+$16.8M

Total Shares Change

+83,299

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
186,850
-21.7%
$116.5M0.7%$622.81
0
2026-Q1
Decreased
238,725
-15.2%
$184.4M1.1%$770.59
0
2025-Q4
Increased
281,335
+8.6%
$217.2M1.2%$768.90
52
2025-Q3
Increased
259,153
+27.6%
$145.7M0.8%$559.40
53
2025-Q2
Decreased
203,057
-2.1%
$106.6M0.6%$521.53
0
2025-Q1
Increased
207,456
+5.2%
$131.6M0.7%$629.11
45
2024-Q4
Increased
197,266
+25.1%
$140.5M0.7%$705.67
52
2024-Q3
Decreased
157,740
-3.4%
$165.8M0.7%$1,041.41
0
2024-Q2
Increased
163,296
+57.7%
$171.6M0.8%$1,041.20
61
2024-Q1
New
103,551
-
$99.7M0.4%$953.49
50

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used